Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Bagnasco D, Nicola S, Testino E, Brussino L, Pini L, Caminati M, Piccardo F, Canevari RF, Melissari L, Ioppi A, et al. Biomedicines. 2023; 11(9):2424. https://doi.org/10.3390/biomedicines11092424 Abstract The efficacy mepolizumab…